{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:49:13Z","timestamp":1743115753980,"version":"3.40.3"},"publisher-location":"Cham","reference-count":26,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030577957"},{"type":"electronic","value":"9783030577964"}],"license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-57796-4_26","type":"book-chapter","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T05:22:44Z","timestamp":1597900964000},"page":"269-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision Dosing Management with Intelligent Computing in Digital Health"],"prefix":"10.1007","author":[{"given":"Hong","family":"Lu","sequence":"first","affiliation":[]},{"given":"Sara","family":"Rosenbaum","sequence":"additional","affiliation":[]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"issue":"1","key":"26_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1179\/acb.2008.003","volume":"63","author":"K Allegaert","year":"2008","unstructured":"Allegaert, K., et al.: Developmental pharmacology: neonates are not just small adults. Acta Clin. Belg. 63(1), 16\u201324 (2008)","journal-title":"Acta Clin. Belg."},{"issue":"6","key":"26_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1365-2125.2005.02429.x","volume":"59","author":"TN Johnson","year":"2005","unstructured":"Johnson, T.N.: Modelling approaches to dose estimation in children. Br. J. Clin. Pharmacol. 59(6), 663\u2013669 (2005)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"26_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1460-9592.2002.00616.x","volume":"12","author":"BJ Anderson","year":"2002","unstructured":"Anderson, B.J., Meakin, G.H.: Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth. 12(3), 205\u2013219 (2002)","journal-title":"Paediatr Anaesth."},{"issue":"11\u201312","key":"26_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.drudis.2008.03.016","volume":"13","author":"J Alcorn","year":"2008","unstructured":"Alcorn, J., McNamara, P.J.: Using ontogeny information to build predictive models for drug elimination. Drug Discov Today 13(11\u201312), 507\u2013512 (2008)","journal-title":"Drug Discov Today"},{"issue":"1","key":"26_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/157488407779422294","volume":"2","author":"K Allegaert","year":"2007","unstructured":"Allegaert, K., et al.: Determinants of drug metabolism in early neonatal life. Curr Clin Pharmacol 2(1), 23\u201329 (2007)","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"26_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1460-9592.2010.03473.x","volume":"21","author":"AN Edginton","year":"2011","unstructured":"Edginton, A.N.: Knowledge-driven approaches for the guidance of first-in-children dosing. Paediatr Anaesth. 21(3), 206\u2013213 (2011)","journal-title":"Paediatr Anaesth."},{"issue":"9","key":"26_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2165\/00003088-200645090-00005","volume":"45","author":"TN Johnson","year":"2006","unstructured":"Johnson, T.N., Rostami-Hodjegan, A., Tucker, G.T.: Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin. Pharmacokinet. 45(9), 931\u2013956 (2006)","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"26_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2165\/00003088-200645070-00004","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton, A.N., et al.: A mechanistic approach for the scaling of clearance in children. Clin. Pharmacokinet. 45(7), 683\u2013704 (2006)","journal-title":"Clin. Pharmacokinet."},{"key":"26_CR9","unstructured":"Brunton, L.L., Lazo, J., Parker, K.L. (ed.): Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics. 11th ed. McGraw-Hill Professional, New York (2005)"},{"issue":"3","key":"26_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2165\/00003088-199732030-00004","volume":"32","author":"RJ Bertz","year":"1997","unstructured":"Bertz, R.J., Granneman, G.R.: Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet. 32(3), 210\u2013258 (1997)","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"26_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0278-6915(02)00209-0","volume":"41","author":"JL Dorne","year":"2003","unstructured":"Dorne, J.L., Walton, K., Renwick, A.G.: Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem. Toxicol. 41(2), 201\u2013224 (2003)","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"26_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0278-6915(01)00005-9","volume":"39","author":"JL Dorne","year":"2001","unstructured":"Dorne, J.L., Walton, K., Renwick, A.G.: Uncertainty factors for chemical risk assessment. Human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem. Toxicol. 39(7), 681\u2013696 (2001)","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"26_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.fct.2003.09.002","volume":"42","author":"JL Dorne","year":"2004","unstructured":"Dorne, J.L., Walton, K., Renwick, A.G.: Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment. Food Chem. Toxicol. 42(2), 275\u2013298 (2004)","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"26_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1185\/146300903322012013","volume":"5","author":"SN de Wildt","year":"2003","unstructured":"de Wildt, S.N., Johnson, T.N., Choonara, I.: The effect of age on drug metabolism. Paediatric Perinatal Drug Therapy 5(3), 101\u2013106 (2003)","journal-title":"Paediatric Perinatal Drug Therapy"},{"issue":"1","key":"26_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200645010-00001","volume":"45","author":"S Bjorkman","year":"2006","unstructured":"Bjorkman, S.: Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children: how accurate are available scaling methods? Clin. Pharmacokinet. 45(1), 1\u201311 (2006)","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"26_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1460-9592.2010.03364.x","volume":"21","author":"BJ Anderson","year":"2011","unstructured":"Anderson, B.J., Larsson, P.: A maturation model for midazolam clearance. Paediatr Anaesth. 21(3), 302\u2013308 (2011)","journal-title":"Paediatr Anaesth."},{"issue":"2","key":"26_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/toxsci\/66.2.185","volume":"66","author":"G Ginsberg","year":"2002","unstructured":"Ginsberg, G., et al.: Evaluation of child\/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci. 66(2), 185\u2013200 (2002)","journal-title":"Toxicol. Sci."},{"issue":"13","key":"26_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2165\/00003088-200241130-00005","volume":"41","author":"J Alcorn","year":"2002","unstructured":"Alcorn, J., McNamara, P.J.: Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin. Pharmacokinet. 41(13), 1077\u20131094 (2002)","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"26_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1248\/yakushi.130.613","volume":"130","author":"S Suzuki","year":"2010","unstructured":"Suzuki, S., et al.: Estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, based on physiological liver development and serum protein levels. Yakugaku Zasshi 130(4), 613\u2013620 (2010)","journal-title":"Yakugaku Zasshi"},{"issue":"3","key":"26_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1124\/dmd.106.013359","volume":"35","author":"J Yang","year":"2007","unstructured":"Yang, J., et al.: Misuse of the well-stirred model of hepatic drug clearance. Drug Metab. Dispos. 35(3), 501\u2013502 (2007)","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"26_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/jps.21916","volume":"99","author":"S Schmidt","year":"2010","unstructured":"Schmidt, S., Gonzalez, D., Derendorf, H.: Significance of protein binding in pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 99(3), 1107\u20131122 (2010)","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"26_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","volume":"65","author":"RK Verbeeck","year":"2009","unstructured":"Verbeeck, R.K., Musuamba, F.T.: Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur. J. Clin. Pharmacol. 65(8), 757\u2013773 (2009)","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5\u20136","key":"26_CR23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/bdd.711","volume":"31","author":"T Uchimura","year":"2010","unstructured":"Uchimura, T., et al.: Prediction of human blood-to-plasma drug concentration ratio. Biopharm. Drug Dispos. 31(5\u20136), 286\u2013297 (2010)","journal-title":"Biopharm. Drug Dispos."},{"issue":"10","key":"26_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/j.1552-4604.1993.tb01922.x","volume":"33","author":"DR Guay","year":"1993","unstructured":"Guay, D.R., et al.: Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster. J. Clin. Pharmacol. 33(10), 918\u2013922 (1993)","journal-title":"J. Clin. Pharmacol."},{"key":"26_CR25","doi-asserted-by":"crossref","unstructured":"Basic anatomical and physiological data for use in radiological protection: reference values. ICRP Publication 89. Ann. ICRP, 32(3\u20134), 5-265 (2002)","DOI":"10.1016\/S0146-6453(03)00002-2"},{"issue":"3","key":"26_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/bja\/61.3.302","volume":"61","author":"HM Mathews","year":"1988","unstructured":"Mathews, H.M., et al.: A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery. Br. J. Anaesth. 61(3), 302\u2013307 (1988)","journal-title":"Br. J. Anaesth."}],"container-title":["Advances in Intelligent Systems and Computing","Advances in Intelligent Networking and Collaborative Systems"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-57796-4_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T01:41:23Z","timestamp":1696556483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-57796-4_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"ISBN":["9783030577957","9783030577964"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-57796-4_26","relation":{},"ISSN":["2194-5357","2194-5365"],"issn-type":[{"type":"print","value":"2194-5357"},{"type":"electronic","value":"2194-5365"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"assertion":[{"value":"21 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"INCoS","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Intelligent Networking and Collaborative Systems","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Victoria, BC","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Canada","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2020","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"31 August 2020","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2 September 2020","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"12","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"incos2020","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"http:\/\/voyager.ce.fit.ac.jp\/conf\/incos\/2020\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}